| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| SRF |
HEL (Erythro Leukemia) |
Treatment: No treatment, no TPA Source: HEL-iMKL1 cells |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: Treated with 10ng/ml Dox for 24 hours Source: HEL-iMKL1 cells |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: Treated with 15nM TPA for 24 hours Source: HEL-iMKL1 cells |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
HEL (Erythro Leukemia) |
Treatment: Treated with 10ng/ml Dox & 15nM TPA for 24 horus Genotype: mkl overexpressed |
Permissive
Robust
|
Homo sapiens |
GSE112265
...
|
MA0083.3
|
| SRF |
Ishikawa (endometrial adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BTD
|
MA0083.3
|
| SRF |
HL-1 (cardiac muscle cells) |
|
Permissive
|
Mus musculus |
GSE19065
...
|
MA0083.3
|
| STAT1 |
K562 (myelogenous leukemia) |
Interferon gamma treatment - 6 hours (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EHJ
|
MA0137.3
|
Showing 10 records in page 302
from 358 pages